Minireviews
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 16, 2023; 11(2): 322-331
Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.322
Prospects for the use of olfactory mucosa cells in bioprinting for the treatment of spinal cord injuries
Olga Vladislavovna Stepanova, Grigorii Andreevich Fursa, Svetlana Sergeevna Andretsova, Valentina Sergeevna Shishkina, Anastasia Denisovna Voronova, Andrey Viktorovich Chadin, Ekaterina Konstantinovna Karsuntseva, Igor Vladimirovich Reshetov, Vladimir Pavlovich Chekhonin
Olga Vladislavovna Stepanova, Grigorii Andreevich Fursa, Svetlana Sergeevna Andretsova, Valentina Sergeevna Shishkina, Anastasia Denisovna Voronova, Andrey Viktorovich Chadin, Ekaterina Konstantinovna Karsuntseva, Vladimir Pavlovich Chekhonin, Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Center for Psychiatry and Narcology, Moscow 119034, Russia
Olga Vladislavovna Stepanova, Department of Neurohumoral and Immunological Research, National Medical Research Center of Cardiology, Moscow 121552, Russia
Svetlana Sergeevna Andretsova, Department of Biology, Moscow State University, Moscow 119991, Russia
Igor Vladimirovich Reshetov, Department of Plastic Surgery, I.M. Sechenov First Moscow State Medical University, Moscow 119435, Russia
Vladimir Pavlovich Chekhonin, Department of Medical Nanobiotechnologу, N.I. Pirogov Russian National Research Medical University, Moscow 117997, Russia
Author contributions: Stepanova OV designed the manuscript and drafted the abstract and introduction; Fursa GA drafted the chapters “4D bioprinting in the treatment for spinal cord injuries”and “Conclusions”; Andretsova SS drafted the chapter “Exogenous neurotrophin therapy”; Shishkina VS drafted the chapter “3D bioprinting in the therapy for spinal cords injury”; Voronova AD drafted the chapter “Neural stem cells/progenitor cells”; Chadin AV drafted the chapter “Ensheathing cells”; Karsuntseva EK drafted the chapter “Mesenchymal stem cells”; Reshetov IV contributed to the improvement and revision of the manuscript; Chekhonin VP provided the final approval of the version to be published.
Conflict-of-interest statement: There is no conflict of interest associated with any of the senior authors or other co-authors who contributed their efforts to this manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Olga Vladislavovna Stepanova, PhD, Senior Scientist, Department of Basic and Applied Neurobiology, V.P. Serbsky National Medical Research Centre for Psychiatry and Narcology, 23 Kropotkinsky Lane, Moscow 119034, Russia. sms-34@yandex.ru
Received: September 19, 2022
Peer-review started: September 19, 2022
First decision: November 14, 2022
Revised: November 28, 2022
Accepted: January 5, 2023
Article in press: January 5, 2023
Published online: January 16, 2023
Core Tip

Core Tip: The development of an optimal strategy for the treatment of spinal cord injuries is a relevant and topical issue in modern medicine. Olfactory mucosa cells and neurotrophic factors showed their effectiveness in transplantation into the area of the injured spinal cord. In this review, the authors discuss the possibility of their application in four-dimensional bioprinting to create transplants that would have a complex impact on the transplant-mediated repair of the damaged area of the spinal cord.